Aoy Tomita-Mitchell, PhD

Publications

• Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the Locus on 5q14.3.

  (Guo T, Repetto GM, McDonald McGinn DM, Chung JH, Nomaru H, Campbell CL, Blonska A, Bassett AS, Chow EWC, Mlynarski EE, Swillen A, Vermeesch J, Devriendt K, Gothelf D, Carmel M, Michaelovsky E, Schneider M, Eliez S, Antonarakis SE, Coleman K, Tomita-Mitchell A, Mitchell ME, Digilio MC, Dallapiccola B, Marino B, Philip N, Busa T, Kushan-Wells L, Bearden CE, Piotrowicz M, Hawuła W, Roberts AE, Tassone F, Simon TJ, van Duin EDA, van Amelsvoort TA, Kates WR, Zackai E, Johnston HR, Cutler DJ, Agopian AJ, Goldmuntz E, Mitchell LE, Wang T, Emanuel BS, Morrow BE, International 22q11.2 Consortium/Brain and Behavior Consortium*.) Circ Cardiovasc Genet. 2017 Oct;10(5).

• Ciliopathy variant burden and developmental delay in children with hypoplastic left heart syndrome.

  (Geddes GC, Stamm K, Mitchell M, Mussatto KA, Tomita-Mitchell A.) Genet Med. 2017 06;19(6):711-714.

• Impact of MYH6 variants in hypoplastic left heart syndrome.

  (Tomita-Mitchell A, Stamm KD, Mahnke DK, Kim MS, Hidestrand PM, Liang HL, Goetsch MA, Hidestrand M, Simpson P, Pelech AN, Tweddell JS, Benson DW, Lough JW, Mitchell ME.) Physiol Genomics. 2016 12 01;48(12):912-921.

• Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery.

  (Brenner MK, Clarke S, Mahnke DK, Simpson P, Bercovitz RS, Tomita-Mitchell A, Mitchell ME, Newman DK.) Pediatr Res. 2016 Feb;79(2):318-24.

• Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta-analysis Reveals Novel Potential Critical Regions Involved in Heart Development.

  (Thorsson T, Russell WW, El-Kashlan N, Soemedi R, Levine J, Geisler SB, Ackley T, Tomita-Mitchell A, Rosenfeld JA, Töpf A, Tayeh M, Goodship J, Innis JW, Keavney B, Russell MW.) Congenit Heart Dis. 2015 May-Jun;10(3):193-208.

• Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis.

  (Kim MS, Horst A, Blinka S, Stamm K, Mahnke D, Schuman J, Gundry R, Tomita-Mitchell A, Lough J.) PLoS One. 2015;10(2):e0118670.

• Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.

  (Wagner AJ, Mitchell ME, Tomita-Mitchell A.) Clin Perinatol. 2014 Dec;41(4):957-66.

• Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid.

  (Hidestrand M, Tomita-Mitchell A, Hidestrand PM, Oliphant A, Goetsch M, Stamm K, Liang HL, Castleberry C, Benson DW, Stendahl G, Simpson PM, Berger S, Tweddell JS, Zangwill S, Mitchell ME.) J Am Coll Cardiol. 2014 Apr 01;63(12):1224-1226.

• The inferred cardiogenic gene regulatory network in the mammalian heart.

  (Bazil JN, Stamm KD, Li X, Thiagarajan R, Nelson TJ, Tomita-Mitchell A, Beard DA.) PLoS One. 2014;9(6):e100842.

• Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

  (Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, Singh S, Shahir KS, Tisol WB, Nugent ML, Rao RN, Mackinnon AC, Goodman LR, Simpson PM, Routes JM.) J Clin Immunol. 2013 Jan;33(1):30-9.

• Human gene copy number spectra analysis in congenital heart malformations.

  (Tomita-Mitchell A, Mahnke DK, Struble CA, Tuffnell ME, Stamm KD, Hidestrand M, Harris SE, Goetsch MA, Simpson PM, Bick DP, Broeckel U, Pelech AN, Tweddell JS, Mitchell ME.) Physiol Genomics. 2012 May 01;44(9):518-41.

• Influence of temperature during transportation on cell-free DNA analysis.

  (Hidestrand M, Stokowski R, Song K, Oliphant A, Deavers J, Goetsch M, Simpson P, Kuhlman R, Ames M, Mitchell M, Tomita-Mitchell A.) Fetal Diagn Ther. 2012;31(2):122-8.